Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / SGEN - Seagen lymphoma drug shows 100% progression free survival in Phase 2 trial

SGEN - Seagen lymphoma drug shows 100% progression free survival in Phase 2 trial

Seagen Inc.

2023-12-11 11:40:56 ET

More on Seattle Genetics, Takeda Pharmaceutical, etc.

For further details see:

Seagen lymphoma drug shows 100% progression free survival in Phase 2 trial
Stock Information
Company Name: Seagen Inc.
Stock Symbol: SGEN
Market: NASDAQ
Website: seagen.com
Menu
SGEN SGEN Quote SGEN Short SGEN News SGEN Articles SGEN Message Board
Get SGEN Alerts

News, Short Squeeze, Breakout and More Instantly...